Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated:  10/2/2012
Clinical Research Facility
mi
from
Ann Arbor, MI
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated: 10/2/2012
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated:  10/2/2012
Clinical Research Facility
mi
from
Omaha, NE
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated: 10/2/2012
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated:  10/2/2012
Clinical Research Facility
mi
from
Henderson, NV
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated: 10/2/2012
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated:  10/2/2012
Clinical Research Facility
mi
from
Newark, NJ
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated: 10/2/2012
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated:  10/2/2012
Clinical Research Facility
mi
from
New York, NY
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated: 10/2/2012
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated:  10/2/2012
Clinical Research Facility
mi
from
Ashville, NC
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated: 10/2/2012
Clinical Research Facility
mi
from
Ashville, NC
Click here to add this to my saved trials
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated:  10/2/2012
Clinical Research Facility
mi
from
Tulsa, OK
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated: 10/2/2012
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated:  10/2/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated: 10/2/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated:  10/2/2012
Clinical Research Facility
mi
from
Charleston, SC
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated: 10/2/2012
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated:  10/2/2012
Clinical Research Facility
mi
from
Sioux Falls, SD
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated: 10/2/2012
Clinical Research Facility
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated:  10/2/2012
Clinical Research Facility
mi
from
Dallas, TX
Study to Assess the Clinical Efficacy and Safety of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]), Also Commercially Known as EYLEA™ in Patients With Branch Retinal Vein Occlusion (BRVO)
Status: Enrolling
Updated: 10/2/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  10/3/2012
Clinical Research Facility
mi
from
Phoenix, AZ
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 10/3/2012
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  10/3/2012
Clinical Research Facility
mi
from
Fort Smith, AR
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 10/3/2012
Clinical Research Facility
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  10/3/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 10/3/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  10/3/2012
Clinical Research Facility
mi
from
Aurora, CO
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 10/3/2012
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  10/3/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 10/3/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  10/3/2012
Clinical Research Facility
mi
from
Decatur, GA
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 10/3/2012
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  10/3/2012
Clinical Research Facility
mi
from
Metairie, LA
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 10/3/2012
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  10/3/2012
Clinical Research Facility
mi
from
Baltimore, MD
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 10/3/2012
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  10/3/2012
Clinical Research Facility
mi
from
St. Joseph, MO
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 10/3/2012
Clinical Research Facility
mi
from
St. Joseph, MO
Click here to add this to my saved trials
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  10/3/2012
Clinical Research Facility
mi
from
Henderson, NV
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 10/3/2012
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  10/3/2012
Clinical Research Facility
mi
from
Newark, NJ
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 10/3/2012
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  10/3/2012
Clinical Research Facility
mi
from
New York, NY
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 10/3/2012
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  10/3/2012
Clinical Research Facility
mi
from
Ashville, NC
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 10/3/2012
Clinical Research Facility
mi
from
Ashville, NC
Click here to add this to my saved trials
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  10/3/2012
Clinical Research Facility
mi
from
Cleveland, OH
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 10/3/2012
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  10/3/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 10/3/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  10/3/2012
Clinical Research Facility
mi
from
Chattanooga, TN
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 10/3/2012
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  10/3/2012
Clinical Research Facility
mi
from
Dallas, TX
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 10/3/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  10/3/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 10/3/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  10/3/2012
Clinical Research Facility
mi
from
Norfolk, VA
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 10/3/2012
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery
Phase 2 Study of Ozurdex for Combined Pseudophakic Cystoid Macula Edema and Diabetic Macula Edema After Cataract Surgery
Status: Enrolling
Updated:  10/3/2012
Northern California Retina Vitreous Associates
mi
from
Mountain View, CA
Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery
Phase 2 Study of Ozurdex for Combined Pseudophakic Cystoid Macula Edema and Diabetic Macula Edema After Cataract Surgery
Status: Enrolling
Updated: 10/3/2012
Northern California Retina Vitreous Associates
mi
from
Mountain View, CA
Click here to add this to my saved trials
A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid
A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid
Status: Enrolling
Updated:  10/12/2012
East-West Medical Research Institute
mi
from
Honolulu, HI
A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid
A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid
Status: Enrolling
Updated: 10/12/2012
East-West Medical Research Institute
mi
from
Honolulu, HI
Click here to add this to my saved trials
Study for Recalcitrant Age Related Macular Degeneration
AflibercepT for Subjects Who Are Incomplete Responders to mUltiple Intravitreal Injections of Ranibizumab, Anti-VegF (The TURF Study)
Status: Enrolling
Updated:  10/15/2012
Retina Consultants of Houston
mi
from
Houston, TX
Study for Recalcitrant Age Related Macular Degeneration
AflibercepT for Subjects Who Are Incomplete Responders to mUltiple Intravitreal Injections of Ranibizumab, Anti-VegF (The TURF Study)
Status: Enrolling
Updated: 10/15/2012
Retina Consultants of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
A Six-Week Safety Study of an Investigational Ophthalmic Solution
Status: Enrolling
Updated:  10/16/2012
Contact Alcon for Trial Locations
mi
from
Fort Worth, TX
A Six-Week Safety Study of an Investigational Ophthalmic Solution
Status: Enrolling
Updated: 10/16/2012
Contact Alcon for Trial Locations
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented With Carotenoids
Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented With Carotenoids
Status: Enrolling
Updated:  10/17/2012
University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented With Carotenoids
Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented With Carotenoids
Status: Enrolling
Updated: 10/17/2012
University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Evaluation of the Effectiveness of Two Marketed Multi-Purpose Solutions for Silicone Hydrogel Contact Lenses - Study 1
Evaluation of the Effectiveness of Two Marketed Multi-Purpose Solutions for Silicone Hydrogel Contact Lenses - Study 1
Status: Enrolling
Updated:  10/19/2012
Alcon Call Center
mi
from
Fort Worth, TX
Evaluation of the Effectiveness of Two Marketed Multi-Purpose Solutions for Silicone Hydrogel Contact Lenses - Study 1
Evaluation of the Effectiveness of Two Marketed Multi-Purpose Solutions for Silicone Hydrogel Contact Lenses - Study 1
Status: Enrolling
Updated: 10/19/2012
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Topical Interferon Gamma-1b for Central Serous Chorioretinopathy
Pilot Phase I/II Study of the Treatment of Classic Centeral Serous Chorioretinopathy With Topical Interferon Gamma-1b
Status: Enrolling
Updated:  10/23/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Topical Interferon Gamma-1b for Central Serous Chorioretinopathy
Pilot Phase I/II Study of the Treatment of Classic Centeral Serous Chorioretinopathy With Topical Interferon Gamma-1b
Status: Enrolling
Updated: 10/23/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Corneal Incisions With the IntraLase iFS Femtosecond Laser System
A MULTI-CENTER PROSPECTIVE STUDY TO EVALUATE THE USE OF THE INTRALASE iFS™ FEMTOSECOND LASER SYSTEM TO CREATE CLEAR CORNEAL INCISIONS AND PARACENTESIS INCISIONS FOR CATARACT SURGERY
Status: Enrolling
Updated:  10/23/2012
Eye Surgeons of Indiana
mi
from
Indianapolis, IN
Corneal Incisions With the IntraLase iFS Femtosecond Laser System
A MULTI-CENTER PROSPECTIVE STUDY TO EVALUATE THE USE OF THE INTRALASE iFS™ FEMTOSECOND LASER SYSTEM TO CREATE CLEAR CORNEAL INCISIONS AND PARACENTESIS INCISIONS FOR CATARACT SURGERY
Status: Enrolling
Updated: 10/23/2012
Eye Surgeons of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Corneal Incisions With the IntraLase iFS Femtosecond Laser System
A MULTI-CENTER PROSPECTIVE STUDY TO EVALUATE THE USE OF THE INTRALASE iFS™ FEMTOSECOND LASER SYSTEM TO CREATE CLEAR CORNEAL INCISIONS AND PARACENTESIS INCISIONS FOR CATARACT SURGERY
Status: Enrolling
Updated:  10/23/2012
Cleveland Eye Clinic
mi
from
Breckville, OH
Corneal Incisions With the IntraLase iFS Femtosecond Laser System
A MULTI-CENTER PROSPECTIVE STUDY TO EVALUATE THE USE OF THE INTRALASE iFS™ FEMTOSECOND LASER SYSTEM TO CREATE CLEAR CORNEAL INCISIONS AND PARACENTESIS INCISIONS FOR CATARACT SURGERY
Status: Enrolling
Updated: 10/23/2012
Cleveland Eye Clinic
mi
from
Breckville, OH
Click here to add this to my saved trials
Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Status: Enrolling
Updated:  10/26/2012
Schwartz Laser Eye Center
mi
from
Scottsdale, AZ
Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Status: Enrolling
Updated: 10/26/2012
Schwartz Laser Eye Center
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Status: Enrolling
Updated:  10/26/2012
Katzen Eye Care and Laser Center
mi
from
Boynton Beach, FL
Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Status: Enrolling
Updated: 10/26/2012
Katzen Eye Care and Laser Center
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Status: Enrolling
Updated:  10/26/2012
Center for Excellence in Eye Care
mi
from
Miami, FL
Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Status: Enrolling
Updated: 10/26/2012
Center for Excellence in Eye Care
mi
from
Miami, FL
Click here to add this to my saved trials
Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Status: Enrolling
Updated:  10/26/2012
Eye Surgeons of Indiana
mi
from
Indianapolis, IN
Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Status: Enrolling
Updated: 10/26/2012
Eye Surgeons of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Status: Enrolling
Updated:  10/26/2012
Eye Health Vision Centers
mi
from
North Dartmouth, MA
Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical and Literature Controls.
Status: Enrolling
Updated: 10/26/2012
Eye Health Vision Centers
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
Wayfinding Information Access System for People With Vision Loss
Wayfinding Information Access System for People With Vision Loss
Status: Enrolling
Updated:  10/31/2012
Atlanta VA Medical and Rehab Center, Decatur
mi
from
Decatur, GA
Wayfinding Information Access System for People With Vision Loss
Wayfinding Information Access System for People With Vision Loss
Status: Enrolling
Updated: 10/31/2012
Atlanta VA Medical and Rehab Center, Decatur
mi
from
Decatur, GA
Click here to add this to my saved trials
Yoga for Persons With Severe Visual Impairment
Development of a Yoga Intervention for Symptoms Related to Severe Visual Impairment
Status: Enrolling
Updated:  10/31/2012
Lions Vision and Research Rehabilitation
mi
from
Baltimore, MD
Yoga for Persons With Severe Visual Impairment
Development of a Yoga Intervention for Symptoms Related to Severe Visual Impairment
Status: Enrolling
Updated: 10/31/2012
Lions Vision and Research Rehabilitation
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  11/5/2012
Clinical Research Facility
mi
from
Dallas, TX
Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 11/5/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion
A Single-center, Open-label Study Evaluating the Impact of Repeat Intravitreal Injections of Aflibercept on Capillary Non-Perfusion (CNP) in Subjects With Proliferative Retinopathy and/or Macular Edema Secondary to Proliferative Diabetic Retinopathy and Central Retinal Venous Occlusive Disease
Status: Enrolling
Updated:  11/7/2012
Ophthalmic Consultants of Boston
mi
from
Boston, MA
Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion
A Single-center, Open-label Study Evaluating the Impact of Repeat Intravitreal Injections of Aflibercept on Capillary Non-Perfusion (CNP) in Subjects With Proliferative Retinopathy and/or Macular Edema Secondary to Proliferative Diabetic Retinopathy and Central Retinal Venous Occlusive Disease
Status: Enrolling
Updated: 11/7/2012
Ophthalmic Consultants of Boston
mi
from
Boston, MA
Click here to add this to my saved trials
An Evaluation of Marketed Contact Lens Disinfectant Systems on Eyelid Tissues
Status: Enrolling
Updated:  11/8/2012
Contact Alcon Call Center for Trial Locations (UK)
mi
from
Fort Worth, TX
An Evaluation of Marketed Contact Lens Disinfectant Systems on Eyelid Tissues
Status: Enrolling
Updated: 11/8/2012
Contact Alcon Call Center for Trial Locations (UK)
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis
Relative Efficacy of Loteprednol (Lotemax®) vs. Loteprednol/Tobramycin (Zylet®) in Treatment of Chronic Ocular Surface Inflammation Associated With Meibomian Gland Dysfunction (MGD)/Posterior Blepharitis
Status: Enrolling
Updated:  11/9/2012
Massachusetts Eye & Ear Infirmary
mi
from
Boston, MA
Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis
Relative Efficacy of Loteprednol (Lotemax®) vs. Loteprednol/Tobramycin (Zylet®) in Treatment of Chronic Ocular Surface Inflammation Associated With Meibomian Gland Dysfunction (MGD)/Posterior Blepharitis
Status: Enrolling
Updated: 11/9/2012
Massachusetts Eye & Ear Infirmary
mi
from
Boston, MA
Click here to add this to my saved trials